Social networks
633 8,049Activities
Technologies
Entity types
Location
7 Bd Bourdon, 75004 Paris, France
Paris
France
Employees
Scale: 51-200
Estimated: 76
SIREN
828335174Engaged corporates
48Added in Motherbase
4 years, 9 months agoEmpowering Artificial Intelligence towards Precision Medicine
TheraPanacea is an innovative information technology company devoted to unlocking the power of AI-based solutions to drive innovation in healthcare.
A spin-off of University Paris-Saclay, TheraPanacea works in close cooperation with the most prominent healthcare facilities to combine the power of its proprietary platforms with clinical domain-knowledge.
Today, ART-PlanTM, TheraPanacea dedicated suite for radio-oncology, is used by more than 60 cancer centres across Europe, Africa, Middle-East and the US and is helping to improve care for more than 60,000 patients every year.
TheraPanacea also develops and operates the ART-OmicsTM platform enabling pharmaceutical companies to accelerate clinical research by harnessing AI-based multi-modality biomarker discovery in clinical trials and their effective integration within the clinical workflow at scale in the form of certified medical devices.
healthcare, radiation therapy, radiation oncology, cancer care, and artificial intelligence
Empowering Artificial Intelligence towards Precision Medicine
TheraPanacea is an innovative information technology company devoted to unlocking the power of AI-based solutions to drive innovation in healthcare.
A spin-off of University Paris-Saclay, TheraPanacea works in close cooperation with the most prominent healthcare facilities to combine the power of its proprietary platforms with clinical domain-knowledge.
Today, ART-PlanTM, TheraPanacea dedicated suite for radio-oncology, is used by more than 60 cancer centres across Europe, Africa, Middle-East and the US and is helping to improve care for more than 60,000 patients every year.
TheraPanacea also develops and operates the ART-OmicsTM platform enabling pharmaceutical companies to accelerate clinical research by harnessing AI-based multi-modality biomarker discovery in clinical trials and their effective integration within the clinical workflow at scale in the form of certified medical devices.
Reinventing cancer care through AI - Innovating technology to standardize cancer treatment planning - Adaptive radiotherapy solution
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
CNRS Research, Research Services | CNRS Research, Research Services | Other 10 Oct 2024 | | |
Johnson & Johnson Pharmaceutical, Hospitals and Health Care | Johnson & Johnson Pharmaceutical, Hospitals and Health Care | Other 26 Jan 2024 | | |
Roche Pharmaceutical, Biotechnology, Biotechnology Research | Roche Pharmaceutical, Biotechnology, Biotechnology Research | Other 6 Jun 2024 | | |
Campus Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | Campus Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | Other 7 Nov 2023 | | |
CNRS Innovation Research, Research Services | CNRS Innovation Research, Research Services | Other 14 Feb 2023 | | |
Amazon Web Services (AWS) IT services, IT Services and IT Consulting | Amazon Web Services (AWS) IT services, IT Services and IT Consulting | Other 24 Jun 2024 | | |
Paris&Co Startup accelerator & VC, Civic and Social Organizations | Paris&Co Startup accelerator & VC, Civic and Social Organizations | Not capitalistic Partnership Event 21 Dec 2017 | | |
Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Not capitalistic Not partnership Event 18 Feb 2019 2 Oct 2024 | | |
Dassault Systèmes IT services, Software Development | Dassault Systèmes IT services, Software Development | Not capitalistic Partnership Event 15 Oct 2018 | | |
RIVP Real Estate, Social Housing | RIVP Real Estate, Social Housing | Not capitalistic Partnership Event 26 Feb 2018 | |